Hiroki Kusama

Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)

Naoki Niikura, Takashi Yamanaka, Hironori Nomura et al. · npj Breast Cancer · 2023 · 60 citations · Full text

Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer

Hiroki Kusama, Nobuyoshi Kittaka, Ai Soma et al. · Breast Cancer · 2023 · 19 citations

Breast Oncology, Cancer Immunosurveillance, Medicine +10

Prevalence of <i>BRCA1</i> and <i>BRCA2</i> mutations in Japanese patients with triple‑negative breast cancer: A single institute retrospective study

Fumie Fujisawa, Yasuhiro Tamaki, Tazuko Inoue et al. · Molecular and Clinical Oncology · 2021 · 11 citations · Full text

α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation

Harumi Nakamura, Yoji Kukita, Kei Kunimasa et al. · Human Pathology · 2021 · 10 citations

Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis

Azusa Taniguchi, Nobuyoshi Kittaka, Haruka Kanaoka et al. · Anticancer Research · 2022 · 10 citations